• Activity INFORMATION

  Overview

  Micro-learning opportunities were created in response to evidence that learning is maximized when delivered in short and focused ‘bursts.’ In this session, the use of alpha blockers for the management of benign prostatic hyperplasia (BPH) is examined, with a focus on special patient counseling points.
  

  Handouts

  • Slide Document :   21321H01(001).pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Identify appropriate monitoring and patient counseling points when using alpha blocker therapy in the management of benign prostatic hyperplasia (BPH).

  Pharmacy Technician

  Identify appropriate monitoring and patient counseling points when using alpha blocker therapy in the management of benign prostatic hyperplasia (BPH).

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-894110

  Universal Activity Number

  Pharmacist 0798-0000-21-321-H01-P
  Pharmacy Technician 0798-0000-21-321-H01-T
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Peter  Kreckel, RPh Retired Adjunct Assistant Professor, Saint Francis University

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).